Beibei Zhang
- Pharmacology top 5%
- Molecular Biology top 10%
- CRISPR and Genetic Engineering 7
- Natural product bioactivities and synthesis 6
- Advanced biosensing and bioanalysis techniques 5
- DNA Repair Mechanisms 3
- RNA and protein synthesis mechanisms 3
-
- Cancer, Hypoxia, and Metabolism 4
-
- Virus-based gene therapy research 4
-
- Listeria monocytogenes in Food Safety 4
- Journals
- Nature Communications (2 papers)PLANT PHYSIOLOGY (1 paper)Analytical Biochemistry (3 papers)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Beibei Zhang
65 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 129
- Pharmacology 119
- Molecular Biology 901
- Business and International Management 20
- Cancer Research 147
- Complementary and alternative medicine 70
Countries citing papers authored by Beibei Zhang
This map shows the geographic impact of Beibei Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beibei Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beibei Zhang more than expected).
Fields of papers citing papers by Beibei Zhang
This network shows the impact of papers produced by Beibei Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beibei Zhang. The network helps show where Beibei Zhang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Beibei Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 11 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 11 | |
| 6 | 2022 | 11 | |
| 7 | 2022 | 28 | |
| 8 | 2022 | 24 | |
| 9 | 2021 | 8 | |
| 10 | 2021 | 11 | |
| 11 | 2021 | 21 | |
| 12 | 2018 | 54 | |
| 13 | 2018 | 37 | |
| 14 | 2018 | 15 | |
| 15 | 2017 | 5 | |
| 16 | 2014 | 22 | |
| 17 | 2014 | 23 | |
| 18 | 2014 | 19 | |
| 19 | 2012 | 9 | |
| 20 | 2008 | 14 |
About Beibei Zhang
Beibei Zhang is a scholar working on Molecular Biology, Biotechnology and Pharmacology, having authored 68 papers that have together received 1.5k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (7 papers), Natural product bioactivities and synthesis (6 papers), Advanced biosensing and bioanalysis techniques (5 papers), Virus-based gene therapy research (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Listeria monocytogenes in Food Safety (4 papers), DNA Repair Mechanisms (3 papers) and RNA and protein synthesis mechanisms (3 papers). The work is most often cited by research in Pharmacology (119 citations), Molecular Biology (901 citations) and Business and International Management (20 citations). Beibei Zhang has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Chao Xuan, Xiaojun Wu, Hui Wu, Hailian Shi, Fei Huang, Zhi‐Xin Liao, Jinke Wang, Xinhui Xu, Xiaohui Liang and Ren Xu. Their work appears in journals such as Nature Communications, PLANT PHYSIOLOGY and Analytical Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.